Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Momenta Pharmaceuticals Inc

+ Add to Watchlist

MNTA:US

15.1800 USD 0.1100 0.73%

As of 20:10:00 ET on 03/30/2015.

Company Profile for Momenta Pharmaceuticals Inc (MNTA)

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.

Contact Information

Momenta Pharmaceuticals Inc

675 West Kendall Street
Cambridge, MA 02142
United States
Phone: 1-617-491-9700
Fax: 1-617-621-0431

Key Executives for Momenta Pharmaceuticals Inc (MNTA)

Craig A WheelerPresident/CEOMichael FrankenPres:Biosimilars Business/Senior VP
Richard P Shea "Rick"Senior VP/CFOBruce A LeicherSenior VP/Secy/General Cnsl
James M RoachSenior VP:Development/CMOGanesh Venkataraman KaundinyaSenior VP:Research/CSO
John E BishopSenior VP:PharmaceuticalLora L PikeSenior Dir:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil